146 related articles for article (PubMed ID: 10451795)
21. Effects of altered physiologic states on clearance and biodistribution of technetium-99m MAG3, iodine-131 OIH, and iodine-125 iothalamate.
Taylor A; Eshima D
J Nucl Med; 1988 May; 29(5):669-75. PubMed ID: 2967354
[TBL] [Abstract][Full Text] [Related]
22. Comparison of 99mTc-mercaptoacetyltriglycine and [131I]-o-iodohippurate elimination in perfused rat kidney.
Trejtnar F; Laznicek M; Laznickova A
Nucl Med Biol; 2003 Jan; 30(1):45-9. PubMed ID: 12493542
[TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetic characteristics of 99mTc-Ethylene-l-dicysteine (99mTc-EC).
Surma MJ; Wiewiórka J; Szadkowska A; Liniecki J
Nucl Med Rev Cent East Eur; 1999; 2(1):20-7. PubMed ID: 14600996
[TBL] [Abstract][Full Text] [Related]
24. Preliminary results comparing OIH, 99mTc-MAG3 and iothalamate in a rat model of renal ischemia.
Eshima D; Greene J; Taylor A
Contrib Nephrol; 1990; 79():24-7. PubMed ID: 2146085
[No Abstract] [Full Text] [Related]
25. Preclinical evaluation of 99mTc(CO)3-aspartic-N-monoacetic acid, a renal radiotracer with pharmacokinetic properties comparable to 131I-o-iodohippurate.
Lipowska M; Klenc J; Marzilli LG; Taylor AT
J Nucl Med; 2012 Aug; 53(8):1277-83. PubMed ID: 22717977
[TBL] [Abstract][Full Text] [Related]
26. Simplified methods for estimation of 99mTc-pentetate and 131I-orthoiodohippurate plasma clearance in dogs and cats.
Barthez PY; Chew DJ; DiBartola SP
J Vet Intern Med; 2001; 15(3):200-8. PubMed ID: 11380028
[TBL] [Abstract][Full Text] [Related]
27. Simplified technetium-99m-EC clearance in adults from a single plasma sample.
Kabasakal L; Yapar AF; Ozker K; Alkan E; Atay S; Ozçelik N; Onsel C
J Nucl Med; 1997 Nov; 38(11):1784-6. PubMed ID: 9374355
[TBL] [Abstract][Full Text] [Related]
28. (99m)Tc(CO)3(NTA): a (99m)Tc renal tracer with pharmacokinetic properties comparable to those of (131)I-OIH in healthy volunteers.
Taylor AT; Lipowska M; Marzilli LG
J Nucl Med; 2010 Mar; 51(3):391-6. PubMed ID: 20150248
[TBL] [Abstract][Full Text] [Related]
29. [99mTc-MAG3 and 131I-OIH in patients with kidney insufficiency and with normal kidneys].
Keske U; Cordes M; Wilfling M; Hunger J; Hosten N; Gahl G
Rofo; 1990 Mar; 152(3):287-92. PubMed ID: 2157251
[TBL] [Abstract][Full Text] [Related]
30. Comparison of iodine-131 OIH and technetium-99m MAG3 renal imaging in volunteers.
Taylor A; Eshima D; Fritzberg AR; Christian PE; Kasina S
J Nucl Med; 1986 Jun; 27(6):795-803. PubMed ID: 2940350
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and biological evaluation of the four isomers of technetium-99m labeled ethylenecysteamine cysteine ((99m)Tc-ECC), the mono-acid derivative of (99m)tc-L,L-ethylenedicysteine.
Vanbilloen HP; Cleynhens BJ; Verbruggen AM
Nucl Med Biol; 2000 Feb; 27(2):207-14. PubMed ID: 10773551
[TBL] [Abstract][Full Text] [Related]
32. 99Tcm-cystine, a renal function and imaging agent: a comparative study in dog with 131I-hippurate and 99Tcm-glucoheptonate to evaluate its functional and imaging characteristics.
Misra M; Sarkar HS; Chakravarty M; Sanyal S; Ganguly S; Sarkar BR; Chatterjee J; Dobe P; Ghosh S; Banerjee S
Nucl Med Commun; 1994 Nov; 15(11):878-85. PubMed ID: 7870394
[TBL] [Abstract][Full Text] [Related]
33. Technetium-99m-EC and other potential new agents in renal nuclear medicine.
Moran JK
Semin Nucl Med; 1999 Apr; 29(2):91-101. PubMed ID: 10321823
[TBL] [Abstract][Full Text] [Related]
34. A comparison of single plasma sample methods to estimate renal clearance using 99mTc-ethylenedicysteine and 99mTc-mercaptoacetyltriglycine.
Sohaib M; Rafique A; Saeed S; Afshan A
Clin Physiol Funct Imaging; 2013 Sep; 33(5):353-8. PubMed ID: 23701132
[TBL] [Abstract][Full Text] [Related]
35. Technetium-99m-L,L-ethylenedicysteine: a renal imaging agent. I. Labeling and evaluation in animals.
Verbruggen AM; Nosco DL; Van Nerom CG; Bormans GM; Adriaens PJ; De Roo MJ
J Nucl Med; 1992 Apr; 33(4):551-7. PubMed ID: 1532419
[TBL] [Abstract][Full Text] [Related]
36. Biodistribution and renal excretion of isomers of the cationic tracer, (99m)Tc diaminocyclohexane (DACH): biodistribution of cationic renal tracers.
Taylor A; Hansen L; Marzilli LG
Nucl Med Biol; 2001 Apr; 28(3):299-302. PubMed ID: 11323241
[TBL] [Abstract][Full Text] [Related]
37. Reproducibility of 99Tcm-MAG3 clearance in normal volunteers with the two-sample method: comparison with 131I-OIH.
Kanazawa T; Shimizu M; Seto H; Kageyama M; Kameda K; Toyoshima S; Tomizawa G; Watanabe N; Inagaki S
Nucl Med Commun; 1998 Sep; 19(9):899-903. PubMed ID: 10581597
[TBL] [Abstract][Full Text] [Related]
38. Prospective validation of a single sample technique to determine technetium-99m-MAG3 clearance.
Taylor A; Corrigan P; Eshima D; Folks R
J Nucl Med; 1992 Sep; 33(9):1620-2. PubMed ID: 1387682
[TBL] [Abstract][Full Text] [Related]
39. Technetium-99m (99mTc) mercaptoacetyltriglycine: update on the new 99mTc renal tubular function agent.
Eshima D; Taylor A
Semin Nucl Med; 1992 Apr; 22(2):61-73. PubMed ID: 1534184
[TBL] [Abstract][Full Text] [Related]
40. Clinical evaluation of technetium-99m-L,L-ethylenedicysteine in patients with chronic renal failure.
Prvulovich EM; Bomanji JB; Waddington WA; Rudrasingham P; Verbruggen AM; Ell PJ
J Nucl Med; 1997 May; 38(5):809-14. PubMed ID: 9170451
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]